Upgrade to SI Premium - Free Trial

Cytokinetics (CYTK) PT Raised to $110 at Citizens on Strong MYQORZO Launch

August 7, 2026 6:01 AM
Citizens analyst Jason Butler raised the price target on Cytokinetics (NASDAQ: CYTK) to $110.00 (from $105.00) while maintaining a Market ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change